Press Releases
New Risk Capital Fund - S-Refit EFRE Fund Bavaria
The Regensburg joint venture company S-Refit AG has a new fund, S-Refit EFRE Fonds Bayern GmbH, founded in the Region of East Bavaria and thereby providing greater opportunities for investment of capital for small and medium sized companies.
read on
GENEART once again amongst "Technology Fast 50" Companies
The company GENEART AG located in BioPark Regensburg was chosen for the third time in a row as the Top 30 of the fastest growing technology companies in Germany. In the category for Life Science Companies GENEART AG received second place.
read on
US Delegation from Georgia in BioPark Regensburg
A top-notch delegation from Georgia, USA under the leadership of Senator Judson Hill came to Regensburg and laid the foundations for future economic cooperation between Bavaria and the US State on the American East Coast.
read on
27 Million € Lead Investment for Antisense Pharma
The company Antisense Pharma GmbH located in BioPark Regensburg has a capital grant from the VC Fund of MIG AG of 27 million €. The company will inject this capital for the development of its Antisense active substance for malignant types of cancer. The preparations for the last clinical test phase of AP 12009 are already fully underway.
read on
East Bavaria on the way to becoming Bioenergy Centre
The initiation of the pilot running of a biodiesel factory in Regensburg is a further milestone in the development of BioRegio Regensburg into a centre for renewable energy. Recently Schmack Biogas AG, a pioneer in this field in East Bavaria since 1995, announced its partnership with energy giants E.ON to build the largest biogas plant in Europe.
read onARCHIVE
